window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Chrysalis

  • CDMOs & Manufacturing,Cell & Gene Therapy,Movers & Shakers,Pharmaceuticals and therapeutics

    Chrysalis appoints Adam Bartley as chief operating officer

    Chrysalis, a provider of GMP cleanroom hosting and support services [...]

    September 23, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    June 17, 2025
  • CDMOs & Manufacturing,Partnerships & Funding

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    June 16, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Strategies to extend ketamine antidepressant effects identified in new study
    Categories: Central Nervous System, Mental health, Neurosciences, Research & Development
  • Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder
    Categories: Artificial Intelligence, Digital Health, Mental health, Neurosciences, Research & Development
  • Bio-Sourcing and Tiny Cargo partner to develop oral monoclonal antibodies using milk exosomes
    Categories: Biotech, Drug Delivery & Formulation, Drug Development, Partnerships & Funding, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top